{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T15:17:21Z","timestamp":1779895041135,"version":"3.53.1"},"reference-count":71,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2014,7,3]],"date-time":"2014-07-03T00:00:00Z","timestamp":1404345600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0093519","type":"journal-article","created":{"date-parts":[[2014,7,3]],"date-time":"2014-07-03T17:36:46Z","timestamp":1404409006000},"page":"e93519","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":95,"title":["Does D-Cycloserine Enhance Exposure Therapy for Anxiety Disorders in Humans? A Meta-Analysis"],"prefix":"10.1371","volume":"9","author":[{"given":"Helga","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Figueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro Vitor","family":"Mendlowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evandro Silva Freire","family":"Coutinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,7,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1001\/archpsyc.1988.01800350011002","article-title":"One-month prevalence of mental disorders in the United States. Based on five Epidemiologic Catchment Area sites","volume":"(11)","author":"DA Regier","year":"1988","journal-title":"Arch Gen Psychiat 45"},{"key":"ref2","first-page":"4","article-title":"The epidemiology of anxiety disorders: prevalence and societal costs","volume":"(14)","author":"JP Lepine","year":"2002","journal-title":"J Clin Psychiat 63"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1176\/appi.ajp.157.5.669","article-title":"Quality of life in individuals with anxiety disorders","volume":"(5)","author":"MV Mendlowicz","year":"2000","journal-title":"Am J Psychiatry 157"},{"key":"ref4","unstructured":"Kessler RC, Greenberg PE (2002) The economic burden of anxiety and stress disorders. In: Davis KL, Charney D, Coyle JT, Nemeroff C (2002) Lippincott Williams and Wilkins (Eds.), Neuropsychopharmacology: The Fifth Generation of Progress. Philadelphia, PA, 981\u2013992."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4088\/JCP.v60n0702","article-title":"The economic burden of anxiety disorders in the 1990s","volume":"(7)","author":"PE Greenberg","year":"1999","journal-title":"J Clin Psychiat 60"},{"key":"ref6","unstructured":"World Health Organization (2001) The World Health Report 2001: Mental Health - New Understanding, New Hope. Geneva, World Health Organization."},{"key":"ref7","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/sj.mp.4001852","article-title":"Treatment-resistant anxiety disorders","volume":"11","author":"A Bystritsky","year":"2006","journal-title":"Mol Psychiatr"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0006-3223(02)01552-4","article-title":"Context in the clinic: how well do cognitive-behavioral therapies and medications work in combination?","volume":"(10)","author":"EB Foa","year":"2002","journal-title":"Biol Psychiat 52"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1001\/jama.283.19.2529","article-title":"Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial","volume":"(19)","author":"DH Barlow","year":"2000","journal-title":"JAMA 283"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1037\/0022-006X.71.6.1058","article-title":"Cognitive therapy versus fluoxetine in generalized social phobia: a randomized placebo-controlled trial","volume":"(6)","author":"DM Clark","year":"2003","journal-title":"J Consult Clin Psychol 71"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1176\/appi.ajp.162.1.151","article-title":"Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder","volume":"162","author":"EB Foa","year":"2005","journal-title":"Am J Psychiat"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"621","DOI":"10.4088\/JCP.v69n0415","article-title":"Cognitive-behavioral therapy for adult anxiety disorders: A meta-analysis of randomized placebo-controlled trials","volume":"(4)","author":"SG Hofmann","year":"2008","journal-title":"J Clin Psychiat 69"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/da.20329","article-title":"Novel treatment approaches for refractory anxiety disorders","volume":"25","author":"MH Pollack","year":"2008","journal-title":"Depress Anxiety"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0193-953X(05)70283-5","article-title":"Definition and epidemiology of treatment-resistant depression","volume":"(2)","author":"M Fava","year":"1996","journal-title":"Psychiatr Clin North Am 19"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/NMD.0b013e3181cc41b6","article-title":"Meta-Analysis of Dropout Rates in SSRIs Versus Placebo in Randomized Clinical Trials of PTSD","volume":"(2)","author":"I Lurie","year":"2010","journal-title":"J Nerv Ment Dis 198"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1521\/psyc.2008.71.2.134","article-title":"Nonresponse and Dropout Rates in Outcome Studies on PTSD: Review and Methodological Considerations","volume":"(2)","author":"MA Schottenbauer","year":"2008","journal-title":"Psychiatry 71"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1023\/B:JOTS.0000004078.93012.7d","article-title":"Do Patients Drop Out Prematurely From Exposure Therapy for PTSD?","volume":"(6)","author":"EA Hembree","year":"2003","journal-title":"J Trauma Stress 16"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1001\/archpsyc.56.1.21","article-title":"A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia","volume":"(1)","author":"DC Goff","year":"1999","journal-title":"Arch Gen Psychiat 56"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1176\/ajp.156.3.467","article-title":"Improved cognition in Alzheimer\u2019s disease with short-term d-cycloserine treatment","volume":"(3)","author":"GE Tsai","year":"1999","journal-title":"Am J Psychiat 156"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10879-011-9195-z","article-title":"A new appraisal of combined treatments for PTSD in the era of psychotherapy adjunctive medications","volume":"42","author":"CM Sheering","year":"2012","journal-title":"J Contemp Psychother"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1523\/JNEUROSCI.22-06-02343.2002","article-title":"Facilitation of Conditioned Fear Extinction by Systemic Administration or Intra-Amygdala Infusions of D-Cycloserine as Assessed with Fear-Potentiated Startle in Rats","volume":"(6)","author":"DL Walker","year":"2002","journal-title":"J Neurosci 22"},{"key":"ref22","unstructured":"American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association."},{"key":"ref23","unstructured":"American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders. Text revision DSM-IV-TR. 4<sup>th<\/sup> edition. Washington, DC: American Psychiatric Association."},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Higgins JPT, Altman DG (2008) Assessing risk of bias in included studies. In: Higgins JPT, Green S (2008) Cochrane handbook for systematic reviews of interventions. Wiley-Blackwell: 188\u2013241.","DOI":"10.1002\/9780470712184.ch8"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"JPT Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.biopsych.2010.07.015","article-title":"A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder","volume":"(11)","author":"EA Storch","year":"2010","journal-title":"Biol Psychiat 68"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/00004583-199706000-00023","article-title":"Children\u2019s Yale-Brown Obsessive Compulsive Scale: Reliability and validity","volume":"(6)","author":"L Scahill","year":"1997","journal-title":"J Am Acad Child Adolesc Psychiat 36"},{"key":"ref28","unstructured":"Guy W (1970) Clinical global impression. Manual for the ECDEU assessment battery."},{"key":"ref29","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.biopsych.2006.12.020","article-title":"D-cycloserine augmented exposure therapy for obsessive-compulsive disorder","volume":"(8)","author":"MG Kushner","year":"2007","journal-title":"Biol Psychiat 62"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","article-title":"The Yale\u2013Brown Obsessive Compulsive Scale-I: development, use, and reliability","volume":"46","author":"WK Goodman","year":"1989","journal-title":"Arch Gen Psychiatry"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1176\/appi.ajp.2007.07050776","article-title":"Augmentation of behavior therapy with d-cycloserine for obsessive-compulsive disorder","volume":"(3)","author":"S Wilhelm","year":"2008","journal-title":"Am J Psychiat 165"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/YIC.0b013e32819f8480","article-title":"D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder","volume":"(4)","author":"EA Storch","year":"2007","journal-title":"Int Clin Psychopharm 22"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1001\/archpsyc.61.11.1136","article-title":"Cognitive Enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear","volume":"(11)","author":"KJ Ressler","year":"2004","journal-title":"Arch Gen Psychiat 61"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0005-7894(77)80116-0","article-title":"Comparison of self-report and overt-behavioral procedures for assessing acrophobia","volume":"8","author":"D Cohen","year":"1977","journal-title":"Behav Ther"},{"key":"ref35","first-page":"168","article-title":"Augmentation of exposure therapy with post-session administration of D-cycloserine","volume":"(2)","author":"CD Tart","year":"2012","journal-title":"J Psychiat Res 47"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.4088\/JCP.11m07564","article-title":"Exposure therapy, D-cycloserine, and functional magnetic resonance imaging in patients with snake phobia: a randomized pilot study","volume":"(9)","author":"AM Nave","year":"2012","journal-title":"J Clin Psychiatry 73"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0005-7894(74)80008-0","article-title":"Psychometric description of some specific fear questionnaires","volume":"5(3)","author":"R Klorman","year":"1974","journal-title":"Behav Ther"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.biopsych.2009.07.036","article-title":"Efficacy of D-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder","volume":"(4)","author":"MW Otto","year":"2010","journal-title":"Biol Psychiat 67"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1176\/ajp.154.11.1571","article-title":"Multicenter collaborative panic disorder severity scale","volume":"154","author":"MK Shear","year":"1997","journal-title":"Am J Psychiat"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.jpsychires.2011.01.020","article-title":"D-cycloserine does not improve but might slightly speed up the outcome of in-vivo exposure therapy in patients with severe agoraphobia and panic disorder in a randomized double blind clinical trial","volume":"(8)","author":"A Siegmund","year":"2011","journal-title":"J Psychiat Res 45"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00004850-199506000-00003","article-title":"Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia Scale","volume":"(2)","author":"B Bandelow","year":"1995","journal-title":"Int Clin Psychopharm 10"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/archpsyc.63.3.298","article-title":"Augmentation of exposure therapy with D-cycloserine for social anxiety disorder","volume":"(3)","author":"SG Hofmann","year":"2006","journal-title":"Arch Gen Psychiat 63"},{"key":"ref43","unstructured":"DiNardo PA (1994) Anxiety disorders interview schedule for DSM-IV: lifetime version (ADIS-IV-L). New York: Graywind Publicatons."},{"key":"ref44","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1037\/1040-3590.1.1.35","article-title":"An empirically derived inventory to measure social fears and anxiety: the Social Phobia and Anxiety Inventory","volume":"1","author":"SM Turner","year":"1989","journal-title":"Psychol Assess"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000414022","article-title":"Social phobia","volume":"22","author":"MR Liebowitz","year":"1987","journal-title":"Mod Probl Pharmacopsychiatry"},{"key":"ref46","first-page":"544","article-title":"A randomized controlled trial of D-Cycloserine enhancement of exposure therapy for social anxiety disorder. Biol","volume":"(6)","author":"AJ Guastella","year":"2008","journal-title":"Psychiat 63"},{"key":"ref47","unstructured":"Brown T (1994) Anxiety disorders interview schedule adult version (ADIS-IV). San Antonio (TX): Psychological Corporation\/Graywind Publications."},{"key":"ref48","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1192\/bjp.bp.106.028167","article-title":"Treatment of social phobia through pure self help and therapist-augmented self help","volume":"191","author":"RM Rapee","year":"2007","journal-title":"Br J Psychiatry"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.biopsych.2012.02.033","article-title":"A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder","volume":"(11)","author":"RA Kleine","year":"2012","journal-title":"Biol Psychiat 71"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.jpsychires.2012.05.006","article-title":"A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder","volume":"(9)","author":"BT Litz","year":"2012","journal-title":"J Psychiat Res 46"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.biopsych.2008.01.012","article-title":"A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy","volume":"(12)","author":"MM Norberg","year":"2008","journal-title":"Biol Psychiat 63"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4088\/JCP.11r07356","article-title":"D-cycloserine augmentation of behavioral therapy for the treatment of anxiety disorders: a meta-analysis","volume":"(4)","author":"A Bontempo","year":"2012","journal-title":"J Clin Psychiat 73"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.psc.2010.04.008","article-title":"Augmentation of cognitive behavioral therapy with pharmacotherapy","volume":"(3)","author":"KA Ganasen","year":"2010","journal-title":"Psychiatr Clin N Am 33"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1527-3458.2006.00208.x","article-title":"Augmentation treatment of psychotherapy for anxiety disorders with D-cycloserine","volume":"(3\u20134)","author":"SG Hofmann","year":"2006","journal-title":"CNS Drug Rev 12"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.2174\/138161212803530916","article-title":"D-cycloserine as an augmentation strategy for cognitive behavioral therapy for anxiety disorders: an update","volume":"18","author":"SG Hofmann","year":"2012","journal-title":"Curr Pharm Des"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1016\/S0028-3908(00)00090-3","article-title":"Chronic treatment with antidepressants affects glycine\/NMDA receptor function: behavioral evidence","volume":"(12)","author":"P Popik","year":"2000","journal-title":"Neuropharmacol 39"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Otto MW, Basden SL, Leyro TM, McHugh RK, Hofmann SG (2007) Clinical perspectives on the combination of D-cycloserine and cognitive-behavioral therapy for the treatment of anxiety disorders. CNS Spectr 12 (1): 51\u201366, 59\u201361.","DOI":"10.1017\/S1092852900020526"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0006-8993(93)91239-O","article-title":"Desensitization of the NMDA receptor complex by glycinergic ligands in cerebellar granule cell cultures","volume":"(2)","author":"KM Boje","year":"1993","journal-title":"Brain Res 603"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0014-2999(94)90687-4","article-title":"Acutebut not chronic activation of the NMDA-coupled glycine receptor with D-cycloserine facilitates learning and retention","volume":"(1\u20132)","author":"D Quartermain","year":"1994","journal-title":"Eur J Pharmacol 257"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"9009","DOI":"10.1523\/JNEUROSCI.21-22-09009.2001","article-title":"Consolidation of extinction learning involves transfer from NMDA-independent to NMDA-dependent memory","volume":"(22)","author":"E Santini","year":"2001","journal-title":"J Neurosci 21"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1037\/0735-7044.117.2.341","article-title":"Effects of D-cycloserine on extinction of conditioned freezing","volume":"(2)","author":"L Ledgerwood","year":"2003","journal-title":"Behav Neurosci 117"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.brat.2010.03.007","article-title":"Need for speed: evaluating slopes of OCD recovery in behavior therapy enhanced with D-cycloserine","volume":"48","author":"GS Chasson","year":"2010","journal-title":"Behav Res Ther"},{"key":"ref63","first-page":"45","article-title":"IV glycine and oral D-cycloserine effects on plasma and CSF amino acids in healthy humans","volume":"47","author":"DC DeSouza","year":"2000","journal-title":"Biol Psychiatry"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1017\/S1461145702003061","article-title":"Pilot-controlled trial of D-cycloserine for the treatment of post-traumatic stress disorder","volume":"5","author":"U Heresco-Levy","year":"2002","journal-title":"Int J of Neuropsychoph"},{"key":"ref65","first-page":"34","article-title":"Cognitive-behavioral therapy for the treatment of anxiety disorders","volume":"(5)","author":"MW Otto","year":"2004","journal-title":"J Clin Psychiatry 65"},{"key":"ref66","first-page":"155","article-title":"Potential biomarkers of cognitive behavior-therapy for post-traumatic stress disorder: a systematic review","volume":"(4)","author":"R Gon\u00e7alves","year":"2011","journal-title":"Rev Psiq Cl\u00edn 38"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1176\/appi.ajp.2013.13040503","article-title":"Harnessing n-methyl-d-aspartate receptors for new treatment development in psychiatry: positive lessons from negative studies","volume":"(7)","author":"DC Javitt","year":"2013","journal-title":"Am J Psychiatry 170"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10566-010-9094-6","article-title":"D-cycloserine augmentation of cognitive-behavioral therapy: Directions for pilot research in pediatric obsessive-compulsive disorder","volume":"(2)","author":"EA Storch","year":"2010","journal-title":"Child Youth Care For 39"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1742-9552.2011.00005.x","article-title":"Using cognitive enhancers to improve the treatment of anxiety disorders in young people: Examining the potential for D-cycloserine to augment exposure for child anxiety","volume":"(1)","author":"SP Byrne","year":"2011","journal-title":"Clin Psychol 15"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.biopsych.2012.12.009","article-title":"D-Cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia","volume":"(11)","author":"JAJ Smits","year":"2013","journal-title":"Biol Psychiatry 73"},{"key":"ref71","first-page":"1","article-title":"D-cycloserine as an augmentation strategy for cognitive behavioral therapy of anxiety disorders","volume":"(11)","author":"SG Hofmann","year":"2013","journal-title":"Biol Mood Anxiety Disord 3"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0093519","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T23:56:27Z","timestamp":1689378987000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0093519"}},"subtitle":[],"editor":[{"given":"Andreas","family":"Reif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,7,3]]},"references-count":71,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2014,7,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0093519","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,3]]}}}